Immunotherapy with radiotherapy for brain metastases in non-small cell lung cancer patients:NEJ060
Immune checkpoint inhibitor (ICI)-based treatment has become standard treatment for advanced non-small cell lung cancer (NSCLC) patients. We aimed to reveal the survival benefit of upfront radiotherapy for brain metastases (BMs) in NSCLC patients who received ICI alone (ICI-alone) or with chemotherapy (ICI-chemo).